相似文献
1
The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples.
Am J Trop Med Hyg. 2010 Mar;82(3):398-401. doi: 10.4269/ajtmh.2010.09-0417.
2
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
Antimicrob Agents Chemother. 2007 Apr;51(4):1172-8. doi: 10.1128/AAC.01313-06. Epub 2007 Jan 12.
3
Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):346-51. doi: 10.1016/j.trstmh.2008.01.021. Epub 2008 Mar 5.
4
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
Antimicrob Agents Chemother. 2006 Oct;50(10):3343-9. doi: 10.1128/AAC.00367-06.
5
Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.
Antimicrob Agents Chemother. 2005 Aug;49(8):3575-7. doi: 10.1128/AAC.49.8.3575-3577.2005.
6
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives.
Wien Klin Wochenschr. 2003;115 Suppl 3:23-7.
7
Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
Malar J. 2013 Jul 12;12:239. doi: 10.1186/1475-2875-12-239.
8
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2417-24. doi: 10.1128/AAC.00527-15. Print 2016 Apr.
9
[Evaluation of in vitro drug sensitivity of antimalarials for Plasmodium falciparum using a colorimetric assay (DELI-microtest)].
Med Trop (Mars). 2001;61(6):545-7.
10
Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.
Antimicrob Agents Chemother. 2007 Jun;51(6):1926-33. doi: 10.1128/AAC.01607-06. Epub 2007 Mar 19.
引用本文的文献
1
Clinically applicable parasite viability assay for rapid assessment of antimalarial pharmacodynamic endpoints.
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0186324. doi: 10.1128/aac.01863-24. Epub 2025 Jun 17.
2
Marine Guanidine Alkaloids Inhibit Malaria Parasites Development in , and Assays.
ACS Infect Dis. 2025 Jul 11;11(7):1854-1867. doi: 10.1021/acsinfecdis.4c00714. Epub 2025 Apr 15.
3
Oleuropein activates autophagy to circumvent anti-plasmodial defense.
iScience. 2024 Mar 11;27(4):109463. doi: 10.1016/j.isci.2024.109463. eCollection 2024 Apr 19.
4
Anti-malarial activity of the alkaloid, heptaphylline, and the furanocoumarin, imperatorin, from Clausena anisata against human Plasmodium falciparum malaria parasites: ex vivo trophozoitocidal, schizonticidal and gametocytocidal approach.
Malar J. 2023 Sep 9;22(1):264. doi: 10.1186/s12936-023-04678-0.
5
Cripowellins Pause Intraerythrocytic Development at the Ring Stage.
Molecules. 2023 Mar 13;28(6):2600. doi: 10.3390/molecules28062600.
6
Rational-Based Discovery of Novel β-Carboline Derivatives as Potential Antimalarials: From In Silico Identification of Novel Targets to Inhibition of Experimental Cerebral Malaria.
Pathogens. 2022 Dec 13;11(12):1529. doi: 10.3390/pathogens11121529.
7
In vitro and in silico assessment of new beta amino ketones with antiplasmodial activity.
Rev Soc Bras Med Trop. 2022 Sep 26;55:e0590. doi: 10.1590/0037-8682-0590-2022. eCollection 2022.
8
Synthesis, Structure−Activity Relationships, and Parasitological Profiling of Brussonol Derivatives as New Plasmodium falciparum Inhibitors.
Pharmaceuticals (Basel). 2022 Jun 30;15(7):814. doi: 10.3390/ph15070814.
9
Selected Derivatives of Erythromycin B- and Anti-Malarial Studies.
Materials (Basel). 2021 Nov 18;14(22):6980. doi: 10.3390/ma14226980.
10
Antiprotozoal and Antibacterial Activity of Ravenelin, a Xanthone Isolated from the Endophytic Fungus .
Molecules. 2021 Jun 2;26(11):3339. doi: 10.3390/molecules26113339.
本文引用的文献
1
Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates.
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):346-51. doi: 10.1016/j.trstmh.2008.01.021. Epub 2008 Mar 5.
2
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
Antimicrob Agents Chemother. 2007 Apr;51(4):1172-8. doi: 10.1128/AAC.01313-06. Epub 2007 Jan 12.
3
High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
Antimicrob Agents Chemother. 2007 Feb;51(2):716-23. doi: 10.1128/AAC.01144-06. Epub 2006 Nov 20.
4
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.
Antimicrob Agents Chemother. 2007 Feb;51(2):651-6. doi: 10.1128/AAC.01023-06. Epub 2006 Nov 20.
5
Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
Am J Trop Med Hyg. 2005 Aug;73(2):239-43.
6
Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing.
Antimicrob Agents Chemother. 2005 Aug;49(8):3575-7. doi: 10.1128/AAC.49.8.3575-3577.2005.
7
Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.
Antimicrob Agents Chemother. 2004 May;48(5):1807-10. doi: 10.1128/AAC.48.5.1807-1810.2004.
8
Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.
Antimicrob Agents Chemother. 2004 May;48(5):1803-6. doi: 10.1128/AAC.48.5.1803-1806.2004.
9
A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.
Am J Trop Med Hyg. 2004 Feb;70(2):119-24.
10
Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.
Exp Parasitol. 1995 Mar;80(2):260-71. doi: 10.1006/expr.1995.1032.
Zotero 插件